AstraZeneca
AstraZeneca pays $460m for cancer specialists
October 15, 2013Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen
AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …
Janssen agrees Zytiga deal
October 14, 2013Sales and Marketing AstraZeneca, Janssen, Zytiga
Janssen has agreed to co-promote its once-daily prostate cancer pill Zytiga with AstraZeneca in Japan for an undisclosed sum. A …
More companies join AZ’s BioHub
October 3, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, alderley
Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …
AstraZeneca pays Merck for cancer drug
September 11, 2013Sales and Marketing AstraZeneca, Cancer, Merck, WEE1
AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …
AstraZeneca begins olaparib programme
September 4, 2013Sales and Marketing AstraZeneca, olaparib, ovarian cancer
AstraZeneca has begun recruitment in its Phase III programme for olaparib, a potential first-in-class oral poly ADP ribose polymerase (PARP) …
Seroquel loss hits AstraZeneca
August 2, 2013Sales and Marketing AstraZeneca, Q2, Seroquel, symbicourt
Loss of exclusivity on brands such as the antipsychotic Seroquel IR helped put a $500 million dent in AstraZeneca’s performance …
AstraZeneca signs $350m kidney deal
August 1, 2013Sales and Marketing AstraZeneca, CKD, fibrogen, kidney
AstraZeneca has signed a deal with private biotech company FibroGen to develop a novel compound aimed at treating anaemia associated …
AstraZeneca staff questioned in China
July 23, 2013Medical Communications, Sales and Marketing AstraZeneca, China, GSK, bribery
AstraZeneca says it has no details on the reasons why three of its employees in China have been questioned by …
Nexium gets its own promotional YouTube channel
July 17, 2013Medical Communications AstraZeneca, Nexium, reflux, youtube
AstraZeneca’s once biggest selling drug Nexium has been given its own YouTube channel in the hope of shoring up sales …
Simon Lowth exits AstraZeneca
July 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth
AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …
AstraZeneca shores up Cambridge move
July 11, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development
AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …
AstraZeneca chooses Cambridge for global HQ
June 19, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune
AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …
MedImmune signs diabetes deal
June 18, 2013Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes
AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
